NCT02089061View on ClinicalTrials.gov

Drug Interaction Statin

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Acute Coronary Syndromes
Interventions
DRUG

BMS-919373

DRUG

Rosuvastatin

DRUG

Atorvastatin

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT02089061 - Drug Interaction Statin | Biotech Hunter | Biotech Hunter